Stock Price & Analysis

The S1 support level for TCMD Stock is $12.86 ,The R1 resistant level for TCMD Stock is $14.03.

As of the end of day on 2025-04-01, the price of TCMD Stock was $12.92.

The target price for TCMD Stock according to analyst rating is 21.50, with the highest price target at 25.00 and the lowest at 18.00. Analysts have a Moderate Buy rating on TCMD Stock overall.

The market cap of TCMD is $321.9M.

Tactile Systems Technology, Inc., doing business as Tactile Medical, is a medical technology company providing therapies for people with chronic disorders. The Company's areas of therapeutic focus are vascular disease, oncology and providing airway clearance therapy for those suffering from chronic respiratory conditions. It is developing and marketing at-home therapies for people suffering from underserved, chronic conditions including lymphedema, lipedema, chronic venous insufficiency and chronic pulmonary disease. It markets Flexitouch Plus and Entre Plus systems as at-home therapies for the treatment of lymphedema and chronic venous insufficiency. The Company markets AffloVest as an at-home therapy intended to promote airway clearance. Its Flexitouch Plus system is a fully automated, programmable, advanced pneumatic compression device. The Company's Entre system is a basic pneumatic compression device. Kylee, its free mobile application, helps patients learn about lymphedema.

TCMD has a total of 992 employees.